Evidence map›Paper›PMID 32779820›Full record

SynthesisTransplant infectious disease : an official journal of the Transplantation Society2020

COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases.

Seyed Ali Moosavi, Amirali Mashhadiagha, Nasrin Motazedian, Alireza Hashemazar, Amir Human Hoveidaei, Davide Bolignano

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Transplant infectious disease : an official journal of the Transplantation Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 5 pooled it
0.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 5 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. COVID-19 and solid organ transplantation: Finding the right balance.Transplantation reviews (Orlando, Fla.) · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases.Transplant infectious disease : an official journal of the Transplantation Society · 2020
    Pooled it
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Long-term follow-up of SARS-CoV-2 recovered renal transplant recipients: A single-center experience from India.Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Article
  12. Viral infections in lung transplantation.Journal of thoracic disease · 2021
    Review
  13. Review
  14. Review
  15. Review
  16. Impact of COVID-19 in solid organ transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Seyed Ali MoosaviTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-6128-7717
Amirali MashhadiaghaTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-8953-8979
Nasrin MotazedianTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0001-9534-4014
Alireza HashemazarStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Amir Human HoveidaeiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0003-4607-354X
Davide BolignanoDepartment of Surgical and Medical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
Shiraz University of Medical Sciences · IRMagna Graecia University · IT

Funding

Shiraz Transplant Research Center, Shiraz University of Medical Sciences 99-01-15-22506
6 · The paper itself

Abstract

backgroundCOVID-19 has been spreading worldwide with a significant death toll. Solid-organ transplantation (SOT) recipients are at higher risk due to their suppressed immune system. In this study, we aimed to conduct a systematic review on COVID-19 clinical manifestations and treatment strategies in SOT recipients.

methodsWe searched three databases for relevant terms related to COVID-19 and transplantation. 50 studies, including 337 patients, were reviewed.

resultsTwo hundred thirty six patients were male, with a mean age of 49.9 years. The most prevalent group was the kidney 57.0%, followed by 17.2% heart and 13.6% liver. Fever and cough were the most reported clinical presentations. Infiltration (55.4%) in chest x-ray and ground-glass opacity (67.1%) in CT scans were the most radiological findings. It was found that 96.8% and 72.4% of patients present with CRP level and lymphocytopenia, respectively, and 70.6% of kidney recipients patients presented with high creatinine levels. The most common baseline immunosuppressants were calcineurin inhibitors (88.9%) and antimetabolites (73.2%). Antimetabolites (84.3%) and calcineurin inhibitors (54.3%) were discontinued/decreased 84.3% whereas glucocorticoids dosage almost has no change (77.9%) or even increased. 18.4% of cases had died, and 65.9% were discharged.

conclusionsPatients' demographics, signs, symptoms, and radiographic findings in SOT recipients are almost similar to the general population. However, gastrointestinal symptoms appear to be more common. There are different treatment strategies, but in most of them, antimetabolite and calcineurin inhibitors were decreased or discontinued, while corticosteroids were increased. Finally, COVID-19 seems to be more severe and has higher mortality in SOT recipients compared to the general population.

Indexed as

COVID-19 Drug TreatmentOrgan TransplantationTransplant RecipientsAdultAntimetabolitesCalcineurin InhibitorsCoughCOVID-19Databases, FactualFemaleFeverGlucocorticoidsHumansImmunocompromised HostImmunosuppressive AgentsLymphopeniaAntimetabolitesCalcineurin InhibitorsGlucocorticoidsImmunosuppressive Agentsclinical manifestationCOVID-19radiographysystematic reviewtransplantationtreatment

Identifiers

PMID32779820
PMCPMC7404594
OpenAlexW3045168540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.